A range of undisclosed private investors and high net-worth individuals took part in the round.
Gliacure, a spin-out of Tufts University, has closed its series B round at $5.8m. Investors in the round remain undisclosed, but include a range of private investors and high net-worth individuals.
The round exceeded the company’s goal of $5m and puts total funds at $8.55m. The spin-out previously raised $2.75m in a 2012 series A round.
Gliacure is working on treatments for various neurological and neuropsychiatric disorders of the brain. It holds an exclusive license from Tufts for a compound…
